# A Study of Monthly Risedronate for Osteoporosis

> **NCT00247273** · PHASE3 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 1294 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** risedronate
- **DRUG:** risedronate

## Key facts

- **NCT ID:** NCT00247273
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 1294 (ACTUAL)
- **Last updated:** 2013-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247273, "A Study of Monthly Risedronate for Osteoporosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00247273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*